Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:04 PM
Ignite Modification Date:
2025-12-24 @ 1:04 PM
NCT ID:
NCT02100761
Eligibility Criteria:
Inclusion Criteria:
* Proven, probable, or possible invasive pulmonary aspergillosis (IPA)
* Acute IPA defined as duration of clinical syndrome of \<30 days.
* Treatment with voriconazole
* At least 18 years and older
* Weight \>40 kg and ≤120 kg
* Given the informed consent
Exclusion Criteria:
* Patients allergic to azole(s)
* Patients who heve been prescribed voriconazole before
* Positive urine pregnancy test (if female)
* Patients with aspergilloma or chronic aspergillosis ( \>1 month duration )
* Anticipated survival of less than 5 days or Karnofsky score \<=20
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02100761
Study Brief:
Protocol Section:
NCT02100761